» Articles » PMID: 30571185

Genomic Risk Stratification Predicts All-Cause Mortality After Cardiac Catheterization

Overview
Date 2018 Dec 21
PMID 30571185
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronary artery disease (CAD) is influenced by genetic variation and traditional risk factors. Polygenic risk scores (PRS), which can be ascertained before the development of traditional risk factors, have been shown to identify individuals at elevated risk of CAD. Here, we demonstrate that a genome-wide PRS for CAD predicts all-cause mortality after accounting for not only traditional cardiovascular risk factors but also angiographic CAD itself.

Methods: Individuals who underwent coronary angiography and were enrolled in an institutional biobank were included; those with prior myocardial infarction or heart transplant were excluded. Using a pruning-and-thresholding approach, a genome-wide PRS comprised of 139 239 variants was calculated for 1503 participants who underwent coronary angiography and genotyping. Individuals were categorized into high PRS (hiPRS) and low-PRS control groups using the maximally selected rank statistic. Stratified analysis based on angiographic findings was also performed. The primary outcome was all-cause mortality following the index coronary angiogram.

Results: Individuals with hiPRS were younger than controls (66 years versus 69 years; P=2.1×10) but did not differ by sex, body mass index, or traditional risk-factor profiles. Individuals with hiPRS were at significantly increased risk of all-cause mortality after cardiac catheterization, adjusting for traditional risk factors and angiographic extent of CAD (hazard ratio, 1.6; 95% CI, 1.2-2.2; P=0.004). The strongest increase in risk of all-cause mortality conferred by hiPRS was seen among individuals without angiographic CAD (hazard ratio, 2.4; 95% CI, 1.1-5.5; P=0.04). In the overall cohort, adding hiPRS to traditional risk assessment improved prediction of 5-year all-cause mortality (area under the receiver-operating curve 0.70; 95% CI, 0.66-0.75 versus 0.66; 95% CI, 0.61-0.70; P=0.001).

Conclusions: A genome-wide PRS improves risk stratification when added to traditional risk factors and coronary angiography. Individuals without angiographic CAD but with hiPRS remain at significantly elevated risk of mortality.

Citing Articles

Genomic Drivers of Coronary Artery Disease and Risk of Future Outcomes After Coronary Angiography.

Supriami K, Urbut S, Tello-Ayala J, Unlu O, Friedman S, Abou-Karam R JAMA Netw Open. 2025; 8(1):e2455368.

PMID: 39836422 PMC: 11751748. DOI: 10.1001/jamanetworkopen.2024.55368.


Considerations for the application of polygenic scores to clinical care of individuals with substance use disorders.

Kember R, Davis C, Feuer K, Kranzler H J Clin Invest. 2024; 134(20).

PMID: 39403926 PMC: 11473164. DOI: 10.1172/JCI172882.


Polygenic risk score predicts all-cause death in East Asian patients with prior coronary artery disease.

Qin M, Wu Y, Fang X, Pan C, Zhong S Front Cardiovasc Med. 2024; 11:1296415.

PMID: 38414927 PMC: 10896892. DOI: 10.3389/fcvm.2024.1296415.


The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology.

Chappell E, Arbour L, Laksman Z J Cardiovasc Dev Dis. 2024; 11(2).

PMID: 38392270 PMC: 10888590. DOI: 10.3390/jcdd11020056.


Clinical applications of polygenic risk score for coronary artery disease through the life course.

Fahed A, Natarajan P Atherosclerosis. 2023; 386:117356.

PMID: 37931336 PMC: 10842813. DOI: 10.1016/j.atherosclerosis.2023.117356.


References
1.
DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

2.
Bjornsson E, Gudbjartsson D, Helgadottir A, Gudnason T, Gudbjartsson T, Eyjolfsson K . Common sequence variants associated with coronary artery disease correlate with the extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35(6):1526-31. PMC: 5903266. DOI: 10.1161/ATVBAHA.114.304985. View

3.
Cohen J, Boerwinkle E, Mosley Jr T, Hobbs H . Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006; 354(12):1264-72. DOI: 10.1056/NEJMoa054013. View

4.
Khera A, Emdin C, Drake I, Natarajan P, Bick A, Cook N . Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med. 2016; 375(24):2349-2358. PMC: 5338864. DOI: 10.1056/NEJMoa1605086. View

5.
LeBlanc M, Zuber V, Andreassen B, Witoelar A, Zeng L, Bettella F . Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors. Circ Res. 2015; 118(1):83-94. PMC: 5609485. DOI: 10.1161/CIRCRESAHA.115.306629. View